Drawing for BINDALINE

USPTO serial 75059383

BINDALINE

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
SMITH, LAURA E
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BINDALINE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jay H. Geller

JAY H GELLER A PROFESSIONAL CORPORATION2425 W OLYMPIC BL E TWRSTE 600SANTA MONICA, CA 90404

Goods and services

ClassDescriptionStatusFirst use
001reagents and biological reagents for scientific research use; reagents and biological reagents for scientific research use in identification of monoclonal antibodies derived from mice, rats and cell cultures; and antibodies for use in vitro scientific researchABANDONED—
005diagnostic and dipstick test kits consisting primarily of one or more of the following - calibrating solutions, reagents, controls, buffers, calibrators, diluents, nitrocellulose membranes, antibodies, substrates, conjugates, stopping solutions, antisera, and/or all for use in measuring the concentration of proteins, antibodies, antigens and other substances in body fluids and for use in identification of monoclonal antibodies derived from mice, rats and cell cultures, for use in the diagnosis, treatment, prevention, cure and mitigation of diseases and other conditions in humans, and parts and fitting sold therewith; and reagents, controls, buffers, calibration solutions, diluents, antibodies, substrates, conjugates, stopping solutions, antisera, all for use in measuring the concentration of proteins, antibodies, antigens and other substances in body fluids and for use in identification of monoclonal antibodies derived from mice, rats and cell cultures, for use in the diagnosis, treatment, prevention, cure and mitigation of diseases and other conditions in humansABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (ABN6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
May 7, 1998ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 29, 1997EX1GSOU EXTENSION 1 GRANTED—
Aug 8, 1997EXT1SOU EXTENSION 1 FILED—
May 6, 1997NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 11, 1997PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 10, 1997NPUBNOTICE OF PUBLICATION—
Dec 3, 1996CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 25, 1996CNEAEXAMINER'S AMENDMENT MAILED—
Sep 19, 1996CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 13, 1996CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 22, 1996DOCKASSIGNED TO EXAMINER—
May 23, 1996CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—

Frequently asked questions

Related guidance